FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110196054> ?p ?o ?g. }

• W2110196054 endingPage "2586" @default.
• W2110196054 startingPage "2579" @default.
• W2110196054 abstract "Abstract Background: Proliferative benign breast conditions are associated with elevated risk of breast cancer, whereas nonproliferative conditions are not strongly associated with risk. Factors acting before onset of hyperplasia might be associated with both benign conditions and breast cancer, whereas those on the proliferative disease-to-cancer pathway would be associated only with cancer. Soy isoflavone exposure may influence breast cancer risk, but little is known of its association with benign conditions. Materials and Methods: We examined possible relationships between plasma genistein and daidzein concentrations and risk of breast disease in women, in a breast self-examination trial in Shanghai, China, diagnosed with breast cancer (n = 196) or a benign breast condition (n = 304), and 1,002 age-matched controls with no known breast disease. Benign conditions were classified as nonproliferative (n = 131) or proliferative with or without atypia (n = 173). Results: Isoflavone concentrations were inversely associated with risk of nonproliferative and proliferative benign fibrocystic conditions, as well as with breast cancer, both with and without concomitant proliferative changes in ipsilateral noncancerous mammary epithelium (Ptrend &lt; 0.01 for all comparisons with controls). Women in the highest quartile of plasma genistein (&gt;76.95 ng/mL) were less likely to have breast cancer (odds ratio, 0.26; 95% confidence interval, 0.13-0.50) or benign conditions (odds ratio, 0.40; 95% confidence interval, 0.23-0.70) compared with women in the lowest quartile (&lt;9.42 ng/mL). Observed risks for breast cancer with and without surrounding proliferative changes were not different, respectively, from observed risks for benign proliferative and nonproliferative conditions alone. Conclusion: Isoflavone exposure was inversely associated with fibrocystic breast conditions and breast cancer, and the results suggest that effects on cancer risk occur early in carcinogenesis. (Cancer Epidemiol Biomarkers Prev 2007;16(12):2579–86)" @default.
• W2110196054 created "2016-06-24" @default.
• W2110196054 creator A5000223213 @default.
• W2110196054 creator A5006533842 @default.
• W2110196054 creator A5008062922 @default.
• W2110196054 creator A5019716896 @default.
• W2110196054 creator A5021222250 @default.
• W2110196054 creator A5030867341 @default.
• W2110196054 creator A5032767656 @default.
• W2110196054 creator A5036251839 @default.
• W2110196054 creator A5042059497 @default.
• W2110196054 creator A5055885406 @default.
• W2110196054 creator A5059950155 @default.
• W2110196054 creator A5070285194 @default.
• W2110196054 creator A5080982010 @default.
• W2110196054 creator A5091846363 @default.
• W2110196054 date "2007-12-01" @default.
• W2110196054 modified "2023-10-16" @default.
• W2110196054 title "Plasma Isoflavones and Fibrocystic Breast Conditions and Breast Cancer Among Women in Shanghai, China" @default.
• W2110196054 cites W1898803632 @default.
• W2110196054 cites W1940053999 @default.
• W2110196054 cites W1967332273 @default.
• W2110196054 cites W1970840105 @default.
• W2110196054 cites W1972503974 @default.
• W2110196054 cites W1980848635 @default.
• W2110196054 cites W1997078642 @default.
• W2110196054 cites W2005085809 @default.
• W2110196054 cites W2010969591 @default.
• W2110196054 cites W2012080390 @default.
• W2110196054 cites W2024541482 @default.
• W2110196054 cites W2029346256 @default.
• W2110196054 cites W2049970571 @default.
• W2110196054 cites W2050476739 @default.
• W2110196054 cites W2058535885 @default.
• W2110196054 cites W2091255782 @default.
• W2110196054 cites W2097063989 @default.
• W2110196054 cites W2099423593 @default.
• W2110196054 cites W2109210673 @default.
• W2110196054 cites W2109743845 @default.
• W2110196054 cites W2112705736 @default.
• W2110196054 cites W2117120389 @default.
• W2110196054 cites W2122967659 @default.
• W2110196054 cites W2127737387 @default.
• W2110196054 cites W2131607744 @default.
• W2110196054 cites W2154207519 @default.
• W2110196054 cites W2189293589 @default.
• W2110196054 cites W2328561181 @default.
• W2110196054 doi "https://doi.org/10.1158/1055-9965.epi-07-0368" @default.
• W2110196054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18086761" @default.
• W2110196054 hasPublicationYear "2007" @default.
• W2110196054 type Work @default.
• W2110196054 sameAs 2110196054 @default.
• W2110196054 citedByCount "51" @default.
• W2110196054 countsByYear W21101960542012 @default.
• W2110196054 countsByYear W21101960542013 @default.
• W2110196054 countsByYear W21101960542015 @default.
• W2110196054 countsByYear W21101960542016 @default.
• W2110196054 countsByYear W21101960542017 @default.
• W2110196054 countsByYear W21101960542018 @default.
• W2110196054 countsByYear W21101960542021 @default.
• W2110196054 countsByYear W21101960542022 @default.
• W2110196054 countsByYear W21101960542023 @default.
• W2110196054 crossrefType "journal-article" @default.
• W2110196054 hasAuthorship W2110196054A5000223213 @default.
• W2110196054 hasAuthorship W2110196054A5006533842 @default.
• W2110196054 hasAuthorship W2110196054A5008062922 @default.
• W2110196054 hasAuthorship W2110196054A5019716896 @default.
• W2110196054 hasAuthorship W2110196054A5021222250 @default.
• W2110196054 hasAuthorship W2110196054A5030867341 @default.
• W2110196054 hasAuthorship W2110196054A5032767656 @default.
• W2110196054 hasAuthorship W2110196054A5036251839 @default.
• W2110196054 hasAuthorship W2110196054A5042059497 @default.
• W2110196054 hasAuthorship W2110196054A5055885406 @default.
• W2110196054 hasAuthorship W2110196054A5059950155 @default.
• W2110196054 hasAuthorship W2110196054A5070285194 @default.
• W2110196054 hasAuthorship W2110196054A5080982010 @default.
• W2110196054 hasAuthorship W2110196054A5091846363 @default.
• W2110196054 hasBestOaLocation W21101960541 @default.
• W2110196054 hasConcept C121608353 @default.
• W2110196054 hasConcept C126322002 @default.
• W2110196054 hasConcept C134018914 @default.
• W2110196054 hasConcept C143998085 @default.
• W2110196054 hasConcept C146304588 @default.
• W2110196054 hasConcept C156957248 @default.
• W2110196054 hasConcept C2775904963 @default.
• W2110196054 hasConcept C2776601875 @default.
• W2110196054 hasConcept C2779880527 @default.
• W2110196054 hasConcept C2908603972 @default.
• W2110196054 hasConcept C29456083 @default.
• W2110196054 hasConcept C530470458 @default.
• W2110196054 hasConcept C71924100 @default.
• W2110196054 hasConceptScore W2110196054C121608353 @default.
• W2110196054 hasConceptScore W2110196054C126322002 @default.
• W2110196054 hasConceptScore W2110196054C134018914 @default.
• W2110196054 hasConceptScore W2110196054C143998085 @default.
• W2110196054 hasConceptScore W2110196054C146304588 @default.
• W2110196054 hasConceptScore W2110196054C156957248 @default.
• W2110196054 hasConceptScore W2110196054C2775904963 @default.

• next